Zhejiang Ruibang Pharmaceutical Co., Ltd. | Pharmaceutical Manufacturer Profile & Drug Portfolio Page 3

Simvastatin Tablets

The main ingredients and their chemical names are: Simvastatin, [1S-[1a, 3a, 7b (2S*, 4S*) 8ab]]-1,2., 3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthyl-2,2-dimethylbutyrate. Molecular formula: C25H38O5, molecular weight: 418.57

Name	Description	Content	CAS NO.	Registered Holders
Simvastatin	This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C). More This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).		79902-63-9	63

Simvastatin Tablets

The main ingredients and their chemical names are: Simvastatin, [1S-[1a, 3a, 7b (2S*, 4S*) 8ab]]-1,2., 3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthyl-2,2-dimethylbutyrate. Molecular formula: C25H38O5, molecular weight: 418.57

Name	Description	Content	CAS NO.	Registered Holders
Simvastatin	This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C). More This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).		79902-63-9	63

Simvastatin Tablets

The main ingredients and their chemical names are: Simvastatin, [1S-[1a, 3a, 7b (2S*, 4S*) 8ab]]-1,2., 3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthyl-2,2-dimethylbutyrate. Molecular formula: C25H38O5, molecular weight: 418.57

Name	Description	Content	CAS NO.	Registered Holders
Simvastatin	This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C). More This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).		79902-63-9	63

3D Glucophosphate Chewable Tablets

This product is a compound preparation. Each tablet contains 150 mg of calcium gluconate (equivalent to 13.5 mg of calcium), 100 mg of calcium hydrogen phosphate (equivalent to 24 mg of calcium), 0.5 mg of vitamin B1, 0.5 mg of vitamin B2, and 1.5 micrograms of vitamin D2 (60 units). Excipients are:

Name	Description	Content	CAS NO.	Registered Holders
CALCIUM GLUCONATE MONOHYDRATE	Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability More Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability	150mg	66905-23-5	35
Calcium phosphate dibasic	Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability More Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability	100mg	7757-93-9	16
Thiamine chloride	It is an essential substance for maintaining normal metabolism and growth and development of the body More It is an essential substance for maintaining normal metabolism and growth and development of the body	0.5mg	59-43-8	9
Riboflavin	It is an essential substance for maintaining normal metabolism and growth and development of the body More It is an essential substance for maintaining normal metabolism and growth and development of the body	0.5mg	83-88-5	19
Vitamin D2	It is an essential substance for maintaining normal metabolism and growth and development of the body More It is an essential substance for maintaining normal metabolism and growth and development of the body	1.5microgram	50-14-6	14

Kitasamycin

Name	Description	Content	CAS NO.	Registered Holders
Sineptina	Extract from the above information More Extract from the above information		1392-21-8	8